S100B and melanoma: Higher level of S100B in preoperative plasma sample compared to lower level (cut‐off value 0.0714 μg/L) was not predictive for patients’ DFI (p = 0.261), OS (p = 0.328), or melanoma recurrence (p = 0.332).